Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07725497) titled 'A Study of Luspatercept in People With Anemia' on July 21.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Memorial Sloan Kettering Cancer Center
Condition:
Anemia
Chronic Kidney Disease
Intervention:
Drug: Luspatercept
Recruitment Status: Recruiting
Phase: Phase 2
Date of First Enrollment: July 20, 2026
Target Sample Size: 30
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07725497
Published by HT Digital Content Services with ...